Skip to content
WhiteIntel
Home
LIVE · CORPUS
SnitchScore · reading…
evidence coverage · reading…
Coverage — measured
Ownership hops held
47

An absent edge means not yet observed — never does not exist.

Legal entityLow

LANTERN PHARMA

LANTERN PHARMA — US company (sec:0001763950). UBO chain traced 47 hops, 26 owners. Every claim linked to its source.

SEC 0001763950CompanyUS
Ownership graph Export .md
JSON / MCPsample
The finding

Ownership resolves 47 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers
Holdings / subsidiaries

None in current sources.

Walk the full UBO chain
47 hops lockedDOSSIER

47-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Verified Dossier€29
Verified Dossier€29

Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.

Everything we hold on LANTERN PHARMA, resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK
  • UBO trace
  • Branded PDF + un-redacted JSON · every claim linked to its source
  • Re-download for 90 days

UBO trace

Guest checkout · email only · re-download 90 days. Or subscribe from €99.

WHAT YOU CAN SEEFREE
YOURS NOW · FREE

4 items you can read right now — no account, no payment.

  • Identity, address & registry profile
  • Sanctions & watchlist detail
  • Direct connections (1 hop)
  • Community notes
YOURS AFTER YOU UNLOCK · PAID

2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

  • Full ownership trace to the UBODOSSIER
  • Full export (PDF + un-redacted JSON) & change alertsDOSSIER
/02

People & control

23 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

23 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns LANTERN PHARMA?
In the current sources, LANTERN PHARMA is connected to BIOS CAPITAL MANAGEMENT, LP, KREIS LESLIE W., BIOS FUND II QP, LP, BIOS FUND I, LP, FLETCHER AARON G.L. and 21 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.
What is LANTERN PHARMA's risk level?
WhiteIntel flags LANTERN PHARMA as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does LANTERN PHARMA appear across sources?
LANTERN PHARMA is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on LANTERN PHARMA. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…

Is this your company?

Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for LANTERN PHARMA — nothing is disclosed before that.

Claim this record